Skip to main content
. 2004 Aug 16;143(2):257–268. doi: 10.1038/sj.bjp.0705927

Figure 7.

Figure 7

(a) Western blot of phosphorylated c-Raf and Percentage of phosphorylated c-Raf evaluated by densitometry (OD mm−2) of the blots in bronchoalveolar lavages of LPS-treated rats 10 min after 2 μM fMLP addition in the presence of PDE4 inhibitors or MAPK inhibitors (C−=negative control, C+=positive control, W=0.05 nM wortmannin). (b) Western blot of phosphorylated MEK1/2 and percentage of phosphorylated MEK1/2 evaluated by densitometry (OD mm−2) of the blots in bronchoalveolar lavages of LPS-treated rats 10 min after 2 μM fMLP addition in the presence of PDE4 inhibitors or MAPK inhibitors (C−=negative control, C+=positive control, PD=PD98059, W=0.05 nM wortmannin).